Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Alaunos Therapeutics
Alaunos Therapeutics is a company that develops clinical stage cellular immuno-oncology solutions.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
Board of Directors
Chris Bowden
0
Mary Thistle
0
Holger Weis
0
Robert Postma
0
Jaime Vieser
0
James Huang
0
Kevin S. Boyle
0
CEO
Kevin S. Boyle
CIK Number
1,107,421
0
Legal Name
Alaunos Therapeutics, Inc.
0
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
alex.lobo@sternir.com
0
info@alaunos.com
0
Full Address
8030 El Rio St Houston, TX 77054
0
Industry
Cell therapy
Stem cell
Healthcare
Immunotherapy
Biotechnology
Biology
Technology
Regenerative medicine
Cancer immunotherapy
T cell
IRS Number
841,475,642
0
Latest Funding Round Date
November 2, 2010
Latest Funding Round Amount (USD)
733,000
Latest Funding Type
Series A
LinkedIn URL
@company/alaunos
Location
Houston
0
Number of Employees (Ranges)
11 – 50
Phone Number
+12126988802
Place of Incorporation
Delaware
0
Previous Name
EasyWeb, Inc.
0
Ziopharm Oncology, Inc.
0
NetEscapes, Inc.
0
SIC Code
2,834
0
Exchange
Nasdaq
0
Stock Symbol
TCRT
0
Ticker Symbol
TCRT
0
Total Funding Amount (USD)
18,833,000
Official Website
alaunos.com
Find more companies like Alaunos Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE